The most frequently prescribed options in the medical industry are semaglutide (the active compound found in Wegovy and Ozempic) and tirzepatide (the active compound in Zepbound and Mounjaro)
Similarly, in non-human primates, GLP-1 receptor agonists including semaglutide have been shown to suppress alcohol intake (Suchankova et al
It helps you clearly define why that patient encounter matters, and helps insurers understand the medical necessity
Comorbidities included hypertensive diseases (I10-I16), Type 2 diabetes mellitus (E11), chronic lower respiratory diseases (J40-J47), neoplasms (C00-D49), psychoactive substance use (F10-F19), ischemic heart diseases (I20-I25), chronic kidney disease (N18), and cerebrovascular diseases (I60-I69)
This strict regimen can be a barrier for some patients, especially those who take other medications that require similar timing
Patients are strongly advised to: Avoid purchasing either compound from unregulated online sources Discuss weight management or body composition concerns with their GP , who can refer to NHS-commissioned weight management services or advise on licensed alternatives Seek information about legitimate clinical trials through the NIHR's Be Part of Research portal (www.bepartofresearch.nihr.ac.uk), which lists UK-based studies that may be recruiting Report any suspected adverse effects from unlicensed peptides or any medicine to the MHRA via the Yellow Card scheme at Which Option May Be More Suitable for Your Needs
